๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Luke Sergott

Stock Analyst at Barclays

(4.65)
# 893
Out of 5,184 analysts
818
Total ratings
50.3%
Success rate
10.1%
Average return

Stocks Rated by Luke Sergott

Revvity
Nov 16, 2026
Reiterated: Hold
Price Target: $175
Current: $145.22
Upside: +20.51%
Twist Bioscience
Nov 13, 2026
Reiterated: Buy
Price Target: $215 → $130
Current: $103.32
Upside: +25.82%
Mettler-Toledo International
Nov 9, 2026
Reiterated: Buy
Price Target: $1,700 → $1,900
Current: $1,666.88
Upside: +13.99%
10x Genomics
Nov 9, 2026
Reiterated: Buy
Price Target: $110 → $70
Current: $51.80
Upside: +35.14%
Certara
Nov 6, 2026
Reiterated: Hold
Price Target: $9 → $12
Current: $10.55
Upside: +13.74%
Guardant Health
Nov 6, 2026
Reiterated: Buy
Price Target: $220
Current: $145.83
Upside: +50.86%
Natera
Nov 6, 2026
Reiterated: Buy
Price Target: $475
Current: $273.40
Upside: +73.74%
Bruker
Nov 5, 2026
Reiterated: Buy
Price Target: $70
Current: $56.46
Upside: +23.98%
Charles River Laboratories International
Nov 5, 2026
Reiterated: Buy
Price Target: $330 → $375
Current: $314.32
Upside: +19.31%
Pacific Biosciences of California
Nov 5, 2026
Reiterated: Sell
Price Target: $1.25 → $2
Current: $1.63
Upside: +22.70%
Reiterated: Buy
Price Target: $22 → $20
Current: $15.91
Upside: +25.71%
Reiterated: Buy
Price Target: $500 → $530
Current: $440.45
Upside: +20.33%
Reiterated: Buy
Price Target: $775
Current: $669.54
Upside: +15.75%
Reiterated: Buy
Price Target: $23 → $26
Current: $18.55
Upside: +40.16%
Reiterated: Sell
Price Target: $200
Current: $192.82
Upside: +3.72%
Reiterated: Buy
Price Target: $440 → $500
Current: $390.30
Upside: +28.11%
Reiterated: Sell
Price Target: $15 → $16
Current: $14.84
Upside: +7.82%
Reiterated: Hold
Price Target: $175 → $230
Current: $186.71
Upside: +23.19%
Reiterated: Buy
Price Target: $300
Current: $245.82
Upside: +22.04%
Reiterated: Hold
Price Target: $330 → $380
Current: $367.13
Upside: +3.51%
Reiterated: Buy
Price Target: $225
Current: $163.81
Upside: +37.35%
Downgraded: Hold
Price Target: $55 → $53
Current: $49.30
Upside: +7.51%
Reiterated: Buy
Price Target: $260
Current: $258.28
Upside: +0.67%
Reiterated: Hold
Price Target: $625 → $675
Current: $610.54
Upside: +10.56%
Reiterated: Buy
Price Target: $255 → $260
Current: $220.36
Upside: +17.99%
Reiterated: Buy
Price Target: $175 → $195
Current: $170.38
Upside: +14.45%
Reiterated: Hold
Price Target: $35 → $42
Current: $3.83
Upside: n/a
Rated: Buy
Price Target: $200
Current: $218.54
Upside: n/a